NYSE · CI
Healthcare · Medical - Healthcare Plans
$298.41
Down-$0.18 (-0.06%)
Updated Oct 30, 2026, 9:28 PM
SID Score
7.6/10
Composite research score
Smart Money
58/100
Neutral
Price performance · CI
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 29, 2026
CI closed at $298.41 after 21 trading sessions, up 11.36% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 29, 2026 | $300.84 | $300.90 | $295.44 | $298.41 | 1.27M |
| Oct 28, 2026 | $296.04 | $299.54 | $294.115 | $295.00 | 1.02M |
| Oct 27, 2026 | $304.68 | $306.74 | $297.00 | $298.28 | 1.36M |
| Oct 26, 2026 | $307.09 | $310.95 | $304.45 | $305.78 | 1.79M |
| Oct 23, 2026 | $314.75 | $315.86 | $305.51 | $306.95 | 1.78M |
| Oct 22, 2026 | $305.73 | $316.265 | $304.675 | $315.88 | 1.58M |
| Oct 21, 2026 | $305.72 | $306.95 | $303.97 | $304.37 | 1.3M |
| Oct 20, 2026 | $302.00 | $307.00 | $300.86 | $306.60 | 1.44M |
| Oct 19, 2026 | $299.00 | $302.15 | $296.32 | $298.50 | 1.23M |
| Oct 16, 2026 | $301.00 | $303.075 | $298.23 | $302.30 | 1.55M |
| Oct 15, 2026 | $293.50 | $300.11 | $292.47 | $298.81 | 2.07M |
| Oct 14, 2026 | $283.85 | $290.08 | $283.56 | $289.58 | 1.4M |
| Oct 13, 2026 | $287.20 | $289.35 | $277.43 | $282.53 | 1.54M |
| Oct 12, 2026 | $283.36 | $285.55 | $281.355 | $283.34 | 970.68K |
| Oct 9, 2026 | $281.16 | $287.89 | $280.46 | $282.43 | 885.42K |
| Oct 8, 2026 | $278.98 | $282.4181 | $275.32 | $281.03 | 1.55M |
| Oct 7, 2026 | $274.88 | $283.125 | $274.76 | $278.51 | 1.63M |
| Oct 6, 2026 | $271.72 | $275.82 | $270.00 | $274.37 | 1.09M |
| Oct 5, 2026 | $270.00 | $273.11 | $266.455 | $271.29 | 1.54M |
| Oct 2, 2026 | $270.03 | $271.40 | $266.00 | $270.53 | 1.91M |
| Oct 1, 2026 | $275.97 | $275.97 | $262.85 | $267.96 | 1.98M |
The latest Smart Investors Daily articles mentioning CI.
Company
Market Activity
Research & News
CI research
Company profile and research snapshot.
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense (current contract through 2029), and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 17 million US and 2 million international medical members covered as of December 2024.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 2, 2026 | Piper Sandler | Overweight | — |
| Oct 1, 2026 | RBC Capital | Outperform | — |
| Aug 4, 2026 | Jefferies | Hold | — |
| Aug 3, 2026 | Raymond James | Outperform | — |
| Jul 31, 2026 | Wells Fargo | Equal-Weight | — |
No generated briefing is available yet.
Benzinga · Oct 22, 2026
Cigna Group (NYSE:CI) has outperformed the market over the past 20 years by 2.08% on an annualized basis producing an average annual return of 11.01%. Currently, Cigna Group has a market capitalization of $81.02
Yahoo · Oct 21, 2026
Molina (MOH) delivered earnings and revenue surprises of +23.61% and +1.42%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Yahoo · Oct 19, 2026
On August 5, 2026, CVS Health (CVS) management raised its fiscal 2026 revenue forecast to at least $414 billion, up from $405 billion in May. Yet the stock has fallen 11.5% since the close prior to that release, compared with a 1.0% dip for the S&P 500. When a higher financial outlook meets a declining share price, investors should examine the technicals before taking the new numbers at face value. So does the CVS Health chart agree with the raise.
Yahoo · Oct 19, 2026
Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an increasingly challenging task.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning CI.
